IndraLab

Statements



reach
"An explanation for this may be that HCQ increases the bioavailability of MTX and/or reduces the clearance of the drug [XREF_BIBR]."

reach
"The multicenter clinical trial TOWARD (TCZ in combination with traditional DMARD therapy) [XREF_BIBR], together with a majority of patients treated with MTX, included 387 patients treated with chloroquine and hydroxychloroquine, sulfasalazine, LEF (N = 97), parenteral gold salts, or azathioprine."